Latest News

: What investors need to know about Pfizer’s latest downgrade

41 views0
By
Share

The company’s pipeline, though promising, is still too premature to make up for the looming drop in COVID-19 franchise revenue. 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
Previous
Next

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News